Dr. Mayo Friedlis
McLean, VA

Since joining National Spine& Pain Centers in 1983, Dr. Friedlis has helped expand the practice into the thriving, nationally recognized leader it is today. He is passionate about the science of pain management and committed to delivering the most effective therapies possible to each of his patients. Throughout his 25+ years of experience he has actively enhanced his knowledge and expertise through continuing education, training and research. This has established him in the region as the foremost practitioner of Regenerative therapies for musculoskeletal injuries.In addition to being skilled in conventional interventional techniques, Dr. Friedlis is one of few physicians in the Washington DC metropolitan area trained to perform Platelet Rich Plasma (PRP) therapy, and is one of the first doctors in the area to use Stem Cell Therapy for musculoskeletal injuries, in particular knee and hip arthritis and has been showing positive results over the last 3 years. “I decided to bring the Regenexx Protocols into the practice, as I believe that they currently represent the highest state of the art for Stem Cell use. The research is strong and ongoing, which is important for the ongoing development of this science.” He is responsible for introducing these advanced regenerative techniques into the arsenal of treatment options now available at National Spine & Pain Centers and StemCell ARTS.

Contact This Doctor
About Dr. Mayo Friedlis
  • Gender Male
  • Hospital Affiliations StemCell ARTS
  • Certifications American Board of Physical Medicine and Rehabilitation
Specialties
  • Physical Medicine and Rehabilitation
  • musculoskeletal injuries

Read Patient Reviews For Dr. Mayo Friedlis
  • Dr Freidlis Review
    My initial appointment with Dr Freidlis was positive, comfortable and reassuring. His recommendation to procede with stem cell treatment as well as full explanations of the procedures, durations and healing outcomes left me feeling confident and reassured to begin treatment this August.



Get our newsletter for the latest news & updates.

Share the knowledge: